GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Silver Spike Investment Corp (NAS:SSIC) » Definitions » Sloan Ratio %

Silver Spike Investment (Silver Spike Investment) Sloan Ratio % : 0.00% (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Silver Spike Investment Sloan Ratio %?

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

Silver Spike Investment's Sloan Ratio for the quarter that ended in Mar. 2024 was 0.00%.

As of Mar. 2024, Silver Spike Investment has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.


Silver Spike Investment Sloan Ratio % Historical Data

The historical data trend for Silver Spike Investment's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Silver Spike Investment Sloan Ratio % Chart

Silver Spike Investment Annual Data
Trend Mar21 Mar22 Dec23
Sloan Ratio %
- - -

Silver Spike Investment Quarterly Data
Jun21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Sloan Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Silver Spike Investment's Sloan Ratio %

For the Drug Manufacturers - Specialty & Generic subindustry, Silver Spike Investment's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Silver Spike Investment's Sloan Ratio % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Silver Spike Investment's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where Silver Spike Investment's Sloan Ratio % falls into.



Silver Spike Investment Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

Silver Spike Investment's Sloan Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Sloan Ratio=(Net Income (A: Dec. 2023 )-Cash Flow from Operations (A: Dec. 2023 )
-Cash Flow from Investing (A: Dec. 2023 ))/Total Assets (A: Dec. 2023 )
=(7.34-5.75
-0)/88.576
=1.80%

Silver Spike Investment's Sloan Ratio for the quarter that ended in Mar. 2024 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Mar. 2024 )
=(5.503-10.434
-0)/90.351
=-5.46%

Silver Spike Investment's Net Income for the trailing twelve months (TTM) ended in Mar. 2024 was 1.211 (Jun. 2023 ) + 1.274 (Sep. 2023 ) + 2.498 (Dec. 2023 ) + 0.52 (Mar. 2024 ) = $5.50 Mil.
Silver Spike Investment's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2024 was 0.352 (Jun. 2023 ) + 0.84 (Sep. 2023 ) + 7.139 (Dec. 2023 ) + 2.103 (Mar. 2024 ) = $10.43 Mil.
Silver Spike Investment's Cash Flow from Investing for the trailing twelve months (TTM) ended in Mar. 2024 was 0 (Jun. 2023 ) + 0 (Sep. 2023 ) + 0 (Dec. 2023 ) + 0 (Mar. 2024 ) = $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Silver Spike Investment  (NAS:SSIC) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Mar. 2024, Silver Spike Investment has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.


Silver Spike Investment Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of Silver Spike Investment's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Silver Spike Investment (Silver Spike Investment) Business Description

Traded in Other Exchanges
N/A
Address
600 Madison Avenue, Suite 1800, New York, NY, USA, 10022
Silver Spike Investment Corp is a closed-end management investment company formed to invest in companies across the cannabis ecosystem through investments in the form of direct loans to, and equity ownership of, privately-held cannabis businesses.
Executives
Umesh Mahajan officer: Chief Financial Officer 600 MADISON AVENUE, SUITE 1800, NEW YORK NY 10022
Scott Gordon director, 10 percent owner, officer: Chief Executive Officer 1114 6TH AVE, 41ST FLOOR, NEW YORK NY 10036
Gregory M. Gentile 10 percent owner, officer: CFO, CCO & Sec. 1114 6TH AVE, 41ST FLOOR, NEW YORK NY 10036
Silver Spike Capital, Llc 10 percent owner 600 MADISON AVE, SUITE 1800, NEW YORK NY 10022
Warson Tracey Brophy director 1350 AVENUE OF THE AMERICAS, NEW YORK NY 10019
Silver Spike Holdings, Lp 10 percent owner 600 MADISON AVENUE, SUITE 1800, NEW YORK NY 10022
Michael William Chorske director 660 MADISON AVENUE, SUITE 1600, NEW YORK NY 10065
Vivek Bunty Bohra director 660 MADISON AVENUE, SUITE 1600, NEW YORK NY 10065
Silver Spike Holdings Gp, Llc 10 percent owner 660 MADISON AVENUE, SUITE 1600, NEW YORK NY 10065
Da Corte Americo director 660 MADISON AVENUE, SUITE 1600, NEW YORK NY 10065

Silver Spike Investment (Silver Spike Investment) Headlines